Vision Global Holdings Limited

Patent Applications and Registrations

Patent applications and USPTO patent grants for Vision Global Holdings Limited.The latest application filed is for "method of treating aml subtypes using arginine-depleting agents".

Company Profile

7.18.13

Vision Global Holdings Limited - Hong Kong CN
Vision Global Holdings Ltd. - Hong Kong CN
VISION GLOBAL HOLDINGS LIMITED - Kowloon HK
VISION GLOBAL HOLDINGS LTD. - Sheung Wan HK

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Method of treating AML subtypes using arginine-depleting agents App 20210401952 - KWOK; Sui-Yi ; et al.	2021-12-30
Method for cancer targeting treatment and detection of arginine using albumin-binding arginine deiminase fusion protein Grant RE48,805 - Wong , et al. November 2, 2	2021-11-02
Compositions for photodynamic therapy and fluorescence diagnosis of cancers and other diseases Grant 10,946,099 - Kwok , et al. March 16, 2	2021-03-16
Mertansine polypeptide conjugates Grant 10,913,770 - Kwok , et al. February 9, 2	2021-02-09
Mertansine Polypeptide Conjugates App 20200361988 - Kwok; Sui-Yi ; et al.	2020-11-19
Pharmaceutical composition comprising modified hemoglobin-based therapeutic agent for cancer targeting treatment and diagnostic imaging Grant 10,322,180 - Wong , et al.	2019-06-18
Compositions For Photodynamic Therapy And Fluorescence Diagnosis Of Cancers And Other Diseases App 20190054173 - KWOK; Sui Yi ; et al.	2019-02-21
Albumin-binding arginine deiminase and the use thereof Grant RE47,233 - Wong , et al. Feb	2019-02-12
Method for cancer targeting treatment and detection of arginine using albumin-binding arginine deiminase fusion protein Grant 9,803,185 - Wong , et al. October 31, 2	2017-10-31
Pharmaceutical Composition Comprising Modified Hemoglobin-based Therapeutic Agent For Cancer Targeting Treatment And Diagnostic Imaging App 20170266285 - WONG; Bing Lou ; et al.	2017-09-21
Pharmaceutical composition comprising modified hemoglobin-based therapeutic agent for cancer targeting treatment and diagnostic imaging Grant 9,636,404 - Wong , et al. May 2, 2	2017-05-02
Albumin-binding Arginine Deiminase For Cancer Targeting Treatment And Detection Of Arginine App 20160115468 - Wong; Bing Lou ; et al.	2016-04-28
Albumin-binding arginine deminase and the use thereof Grant 9,255,262 - Wong , et al. February 9, 2	2016-02-09
Specific Biomarker Set For Non-invasive Diagnosis Of Liver Cancer App 20160003832 - MAN; Cornelia Wing Yin ; et al.	2016-01-07
Specific Biomarker Set For Non-invasive Diagnosis Of Liver Cancer App 20160003833 - MAN; Cornelia Wing Yin ; et al.	2016-01-07
Hemoglobin-based oxygen carrier-containing pharmaceutical composition for cancer targeting treatment and prevention of cancer recurrence Grant 9,056,098 - Wong , et al. June 16, 2	2015-06-16
Pharmaceutical Composition Comprising Modified Hemoglobin-based Therapeutic Agent For Cancer Targeting Treatment And Diagnostic Imaging App 20140335018 - WONG; Bing Lou ; et al.	2014-11-13
Hemoglobin-based Oxygen Carrier-containing Pharmaceutical Composition For Cancer Targeting Treatment And Prevention Of Cancer Recurrence App 20140303085 - WONG; Bing Lou ; et al.	2014-10-09
Pharmaceutical Composition Comprising Albumin-binding Arginine Deiminase For Cancer Targeting Treatment App 20140255377 - WONG; Bing Lou ; et al.	2014-09-11

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.